Cargando…

A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders

Primary and secondary mast cell activation syndromes (MCAS) can occur in patients with mastocytosis. During the past few years our knowledge about the pathogenesis and disease-triggering mechanisms in MCAS and mastocytosis have increased substantially. Whereas mastocytosis is characterized by an acc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romantowski, Jan, Górska, Aleksandra, Niedoszytko, Marek, Gulen, Theo, Gruchała-Niedoszytko, Marta, Nedoszytko, Bogusław, Lange, Magdalena, Brockow, Knut, Arock, Michel, Akin, Cem, Valent, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867197/ https://www.ncbi.nlm.nih.gov/pubmed/33535634 http://dx.doi.org/10.3390/ijms22031454

Ejemplares similares

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
por: Valent, Peter, et al.
Publicado: (2020)

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021)

Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
por: Valent, Peter, et al.
Publicado: (2022)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2016)

Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy
por: Niedoszytko, Marek, et al.
Publicado: (2021)

DNA methylation profile in patients with indolent systemic mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2021)

Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015)

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy
por: Niedoszytko, Marek, et al.
Publicado: (2013)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2023)

Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow
por: Spolak‐Bobryk, Natalia, et al.
Publicado: (2022)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs’ activation and function
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

Clinical Application of In Vitro Tests for COVID-19 Vaccine Delayed Hypersensitivity Diagnostics
por: Romantowski, Jan, et al.
Publicado: (2023)

The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
por: Górska, Aleksandra, et al.
Publicado: (2021)

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2021)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis
por: Ługowska-Umer, Hanna, et al.
Publicado: (2022)

Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis
por: Antoniewicz, Jakub, et al.
Publicado: (2021)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire
por: Spolak-Bobryk, Natalia, et al.
Publicado: (2022)

The role of the clinical and psychological symptoms of mastocytosis in the patient’s quality of life
por: Spolak-Bobryk, Natalia, et al.
Publicado: (2021)

Atopy and Multisensitizations in Specific IgE Microarrays and Their Impact on Severe Asthma
por: Romantowski, Jan, et al.
Publicado: (2022)

Dietary Habits in Children with Respiratory Allergies: A Single-Center Polish Pilot Study
por: Wasilewska, Eliza, et al.
Publicado: (2020)

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
por: Valent, Peter, et al.
Publicado: (2021)

Genetic and Epigenetic Aspects of Atopic Dermatitis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
por: Lange, Magdalena, et al.
Publicado: (2021)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020)

Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective
por: Jang, Tae Young, et al.
Publicado: (2015)

New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood
por: CZARNY, Justyna, et al.
Publicado: (2020)

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis
por: Romantowski, Jan, et al.
Publicado: (2019)

Protocol of safe vaccination against COVID‐19 in patients with high risk of allergic reactions
por: Romantowski, Jan, et al.
Publicado: (2022)

Mastocytosis in children and adults: clinical disease heterogeneity
por: Lange, Magdalena, et al.
Publicado: (2012)

IFNG, FCER1A, PCDHB10 expression as a new potential marker of efficacy in grass pollen allergen-specific immunotherapy
por: Romantowski, Jan, et al.
Publicado: (2021)

The Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases
por: Woźniak, Ewelina, et al.
Publicado: (2023)

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
por: Kennedy, Vanessa E., et al.
Publicado: (2022)

Air Pollution in Poland: A 2022 Narrative Review with Focus on Respiratory Diseases
por: Nazar, Wojciech, et al.
Publicado: (2022)

Changes in Air-Pollution-Related Information-Seeking Behaviour during the COVID-19 Pandemic in Poland
por: Nazar, Wojciech, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejos6ltoli9pt5gcumftg4rsq9